Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Testosterone therapy increases bone density in older men with low testosterone levels.

Finasteride affects male rat genitalia development, causing abnormalities during specific pregnancy days.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

The review suggests new ways to classify ejaculation problems and recommends different treatments based on the type of issue.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

The new finasteride delivery system using chitosan-based nanoniosomes shows promise for prostate cancer prevention.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

A team approach is crucial for managing PCOS, with dermatologists playing a key role.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Dutasteride is more efficient than finasteride, but individual results vary.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

A new method accurately measures nine specific hormones in human blood.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

A thorough initial check-up is essential before sperm banking to ensure the best chance of preserving good quality sperm.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

The UK Court of Appeal ruled that new dosing regimens for drugs can be patented, aligning with the European Patent Office's approach.

The 2018 update to the ED care model added a new severity score and stressed a detailed evaluation of both physical and psychological aspects.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.